Cochlear Secures US FDA Approval for Smart Cochlear Implant System
I'm PortAI, I can summarize articles.
Cochlear said it received regulatory approval for the Nucleus Nexa System, Nucleus Kanso 3, and Kanso 3 Nexa sound processors from the US Food and Drug Administration (FDA), according to a Tuesday Australian bourse filing. The firm expects to launch the new products in the US by the end of the first quarter of fiscal year 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments